Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of “Buy” from Brokerages
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report on the stock […]
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have received a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report on the stock […]
